These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 30773433
1. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges. Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A. Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433 [Abstract] [Full Text] [Related]
2. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study. Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB. Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979 [Abstract] [Full Text] [Related]
3. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test. Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT. Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004 [Abstract] [Full Text] [Related]
4. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease. Dexter D, McGann PT. Br J Haematol; 2022 Jan; 196(1):63-69. PubMed ID: 34340260 [Abstract] [Full Text] [Related]
5. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia. Adegoke SA, Makalo L, Sallah A, Saine H, Joof S, Conteh A, Bah R, Camara Jammeh AF, Bass M, Jallow M, Nnodu OE. Hemoglobin; 2024 May; 48(3):169-174. PubMed ID: 38980121 [Abstract] [Full Text] [Related]
6. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies. Quinn CT, Paniagua MC, DiNello RK, Panchal A, Geisberg M. Br J Haematol; 2016 Nov; 175(4):724-732. PubMed ID: 27605462 [Abstract] [Full Text] [Related]
7. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India. Mukherjee MB, Colah RB, Mehta PR, Shinde N, Jain D, Desai S, Dave K, Italia Y, Raicha B, Serrao E. Am J Clin Pathol; 2020 Jan 01; 153(1):82-87. PubMed ID: 31433854 [Abstract] [Full Text] [Related]
8. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study. Oluwole EO, Adeyemo TA, Osanyin GE, Odukoya OO, Kanki PJ, Afolabi BB. PLoS One; 2020 Jan 01; 15(12):e0242861. PubMed ID: 33270733 [Abstract] [Full Text] [Related]
9. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting. Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R. Pediatrics; 2019 Oct 01; 144(4):. PubMed ID: 31530717 [Abstract] [Full Text] [Related]
10. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia. Mano RM, Kuona P, Misihairabgwi JM. BMC Pediatr; 2024 May 10; 24(1):323. PubMed ID: 38730340 [Abstract] [Full Text] [Related]
11. Towards a point-of-care strip test to diagnose sickle cell anemia. Bond M, Hunt B, Flynn B, Huhtinen P, Ware R, Richards-Kortum R. PLoS One; 2017 May 10; 12(5):e0177732. PubMed ID: 28520780 [Abstract] [Full Text] [Related]
12. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania. Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S. Int J Lab Hematol; 2022 Oct 10; 44(5):959-965. PubMed ID: 35775883 [Abstract] [Full Text] [Related]
13. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood. Guindo A, Cisse Z, Keita I, Desmonde S, Sarro YDS, Touré BA, Baraika MA, Tessougué O, Guindo P, Coulibaly M, Traore O, Sylla N, Diassana M, Saye A, Picot V, Lauressergues E, Leroy V. Br J Haematol; 2024 Jan 10; 204(1):337-345. PubMed ID: 37728227 [Abstract] [Full Text] [Related]
14. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study. Smart LR, Ambrose EE, Raphael KC, Hokororo A, Kamugisha E, Tyburski EA, Lam WA, Ware RE, McGann PT. Ann Hematol; 2018 Feb 10; 97(2):239-246. PubMed ID: 29147848 [Abstract] [Full Text] [Related]
15. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests. Olaniyan HS, Briscoe C, Muhongo M, Pascoal R, Armando A, Santos B, McGann PT. Blood Adv; 2023 Oct 10; 7(19):5860-5867. PubMed ID: 37399450 [Abstract] [Full Text] [Related]
16. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola. McGann PT, Ferris MG, Ramamurthy U, Santos B, de Oliveira V, Bernardino L, Ware RE. Am J Hematol; 2013 Dec 10; 88(12):984-9. PubMed ID: 24038490 [Abstract] [Full Text] [Related]
17. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease. McGann PT, Schaefer BA, Paniagua M, Howard TA, Ware RE. Am J Hematol; 2016 Feb 10; 91(2):205-10. PubMed ID: 26537622 [Abstract] [Full Text] [Related]
18. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area]. Diallo DA, Guindo A, Touré BA, Sarro YS, Sima M, Tessougué O, Baraika MA, Guindo P, Traoré M, Diallo M, Dorie A. Rev Epidemiol Sante Publique; 2018 May 10; 66(3):181-185. PubMed ID: 29625861 [Abstract] [Full Text] [Related]
19. Evaluation of a Portable Haemoglobin Metre Performance in Children with Sickle Cell Disease and Implications for Healthcare in Resource-poor Settings. Olatunya OS, Olu-Taiwo A, Ogundare EO, Oluwayemi IO, Olaleye AO, Fadare JO, Adekoya-Benson T, Fatunla O, Agaja OT, Omoniyi E, Oluwadiya KS. J Trop Pediatr; 2016 Aug 10; 62(4):316-23. PubMed ID: 26995011 [Abstract] [Full Text] [Related]
20. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges. Dexter D, McGann PT. Pharmacotherapy; 2023 May 10; 43(5):430-441. PubMed ID: 36906823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]